The anticonvulsive Phenhydan® suppresses extrinsic cell death

[1]  Carlina Duan.  Programmed , 2020, Pleiades: Literature in Context.

[2]  U. Kunzendorf,et al.  The anticonvulsive Phenhydan® suppresses extrinsic cell death , 2018, Cell Death & Differentiation.

[3]  E. Bieberich.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis. , 2018, Chemistry and physics of lipids.

[4]  Susan S. Taylor,et al.  Kinase domain dimerization drives RIPK3-dependent necroptosis , 2018, Science Signaling.

[5]  Brian J. Smith,et al.  Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis , 2018, Nature Communications.

[6]  Junying Yuan,et al.  Small molecule probes for cellular death machines. , 2017, Current opinion in chemical biology.

[7]  R. Kontermann,et al.  Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2 , 2017, Scientific Reports.

[8]  B. Stockwell,et al.  Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure , 2017, Cellular and Molecular Life Sciences.

[9]  Michelle C. Schaeffer,et al.  Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. , 2017, Journal of medicinal chemistry.

[10]  Chuan-Qi Zhong,et al.  RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome , 2017, Nature Communications.

[11]  P. Vandenabeele,et al.  The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. , 2016, The Journal of clinical investigation.

[12]  Zhirong Shen,et al.  Biomarkers for the detection of necroptosis , 2016, Cellular and Molecular Life Sciences.

[13]  D. Vaux,et al.  Evolutionary divergence of the necroptosis effector MLKL , 2016, Cell Death and Differentiation.

[14]  James M. Murphy.  Faculty Opinions recommendation of Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. , 2015 .

[15]  W. Alexander,et al.  Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop. , 2015, The Biochemical journal.

[16]  G. Superti-Furga,et al.  A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis , 2015, Cell Death and Disease.

[17]  F. Chan,et al.  Programmed necrosis in the cross talk of cell death and inflammation. , 2015, Annual review of immunology.

[18]  I. Parmryd,et al.  Cholesterol depletion using methyl-β-cyclodextrin. , 2015, Methods in molecular biology.

[19]  Kenta Moriwaki,et al.  RIP3 induces apoptosis independent of pronecrotic kinase activity. , 2014, Molecular cell.

[20]  S. Cullen,et al.  RIPK1 can function as an inhibitor rather than an initiator of RIPK3‐dependent necroptosis , 2014, The FEBS journal.

[21]  Qin Chen,et al.  Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense , 2014, Proceedings of the National Academy of Sciences.

[22]  M. Bertrand,et al.  MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. , 2014, Cell reports.

[23]  Xiaodong Wang,et al.  Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. , 2014, Molecular cell.

[24]  L. Komuves,et al.  Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.

[25]  S. Sottini,et al.  The β-Subunit of Cholera Toxin has a High Affinity for Ganglioside GM1 Embedded into Solid Supported Lipid Membranes with a Lipid Raft-Like Composition , 2014, Lipids.

[26]  Toru Okamoto,et al.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.

[27]  J. Bertin,et al.  Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL* , 2013, The Journal of Biological Chemistry.

[28]  D. Green,et al.  Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury , 2013, Proceedings of the National Academy of Sciences.

[29]  W. Schneider-Brachert,et al.  Membrane Trafficking of Death Receptors: Implications on Signalling , 2013, International journal of molecular sciences.

[30]  Chung Hyeok Kim,et al.  Biomedical Importance of Indoles , 2013, Molecules.

[31]  P. Vandenabeele,et al.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models , 2012, Cell Death and Disease.

[32]  R. Dudani,et al.  Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium , 2012, Nature Immunology.

[33]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[34]  Yuqiong Liang,et al.  Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway , 2011, Proceedings of the National Academy of Sciences.

[35]  H. Steller,et al.  Programmed Cell Death in Animal Development and Disease , 2011, Cell.

[36]  J. Bonventre,et al.  Cellular pathophysiology of ischemic acute kidney injury. , 2011, The Journal of clinical investigation.

[37]  D. Kabelitz,et al.  Caspase‐8 and caspase‐7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF‐R1 receptosomes , 2011, The EMBO journal.

[38]  Helgi I. Ingólfsson,et al.  Gramicidin-based fluorescence assay; for determining small molecules potential for modifying lipid bilayer properties. , 2010, Journal of visualized experiments : JoVE.

[39]  S. Johannessen,et al.  Antiepileptic Drug Interactions - Principles and Clinical Implications , 2010, Current neuropharmacology.

[40]  B. Beutler,et al.  Intracellular toll-like receptors. , 2010, Immunity.

[41]  Na Zhang,et al.  RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis , 2009, Science.

[42]  F. Chan,et al.  Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.

[43]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[44]  M. Toyota,et al.  Identification of Flotillin-2, a Major Protein on Lipid Rafts, as a Novel Target of p53 Family Members , 2008, Molecular Cancer Research.

[45]  F. Khuri,et al.  Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. , 2007, Cancer research.

[46]  G. Nixon,et al.  Spatial Compartmentalization of Tumor Necrosis Factor (TNF) Receptor 1-dependent Signaling Pathways in Human Airway Smooth Muscle Cells , 2006, Journal of Biological Chemistry.

[47]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[48]  T. Griffith,et al.  Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  W. D. Dietrich,et al.  Tumor Necrosis Factor Receptor 1 and Its Signaling Intermediates Are Recruited to Lipid Rafts in the Traumatized Brain , 2004, The Journal of Neuroscience.

[50]  L. Chamberlain.  Detergents as tools for the purification and classification of lipid rafts , 2004, FEBS letters.

[51]  Hai-Tao He,et al.  An essential role for membrane rafts in the initiation of Fas/CD95‐triggered cell death in mouse thymocytes , 2002, EMBO reports.

[52]  J. Medin,et al.  A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. , 2001, The Biochemical journal.

[53]  F. Pinguet,et al.  Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice. , 1998, British Journal of Cancer.

[54]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.